INTRODUCTION
============

Metabolic syndrome (MetS) is characterized by the clustering of abdominal obesity, impaired glucose tolerance, elevated triglyceride levels, reduced high-density lipoprotein (HDL) cholesterol levels, and hypertension, often accompanied by a proinflammatory state.^[@r01]^ Persons with MetS are at increased risk of cardiovascular diseases and type 2 diabetes, not only in Western^[@r02]^ but also in Asian populations.^[@r03],[@r04]^ Although less frequent than in Western countries, obesity and MetS are also major health problems in Japan. According to the 2008 National Nutritional and Health Survey, the prevalence of MetS in Japan was estimated at 25.3% for men and 10.6% for women.^[@r05]^

Worldwide, MetS has been diagnosed using several different sets of criteria, such as those of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III),^[@r01]^ the International Diabetes Federation,^[@r06]^ and the Japan Society for the Study of Obesity (JASSO).^[@r03],[@r07]^ These definitions differ somewhat in terms of the prerequisite components and the cut-off levels used for each component.

Lifestyle factors reported to be associated with an increased risk of MetS include a diet with a high intake of refined grains, meat, and fried foods^[@r08]^; low diet quality, ie, high fat and low dietary fiber and vitamins^[@r09]^; and smoking,^[@r10]^ whereas a diet with a high intake of vegetables and fruits,^[@r11]^ and high levels of leisure-time physical activity,^[@r10],[@r12]^ are believed to be protective.

Recently, habitual consumption of coffee^[@r13],[@r14]^ was reported to be a protective factor against development of type 2 diabetes. However, the association between coffee consumption and MetS remains unclear. Two cross-sectional studies in Japan showed inverse correlations of coffee consumption with MetS and some of its components,^[@r15],[@r16]^ while prospective studies performed in the United States^[@r08]^ and Europe^[@r10],[@r17]^ showed no association.

Previous epidemiologic studies performed mainly in Asian countries showed that high intake of tea, green tea, or green tea extracts was associated with decreases in body weight and waist circumference,^[@r18]^ serum triglycerides,^[@r19]^ blood pressure,^[@r20]^ and diabetes incidence.^[@r21]^ However, an association between green tea consumption and MetS has not been proven.

In the present report, we examined the correlation between consumption of coffee and green tea and the prevalence of MetS and its components, as defined using the criteria of NCEP ATP III and JASSO.

METHODS
=======

Study participants
------------------

The population of the present study consisted of 577 men and women aged 35 to 70 years who had attended the Tokushima Prefectural General Health Check-up Center from January 23, 2008 to November 24, 2011 and had participated in the baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. Of 3911 subjects who had received a medical examination during the study period and were asked to participate in the J-MICC Study, 577 (14.8%) agreed. We excluded people with a previous history of stroke (*n* = 5) or ischemic heart disease (*n* = 8) and those whose health check-up data were not available (*n* = 10), which left 554 participants (409 men and 145 women) for the present analysis. The details of the J-MICC Study have been described in a previous report.^[@r22]^ Briefly, the purpose of the J-MICC Study was to examine prospectively the associations of lifestyle and genetic factors and their interactions with the risk of chronic diseases. After thoroughly explaining the outline and purpose of the study, written informed consent was obtained from each participant. The study protocol was reviewed and approved by the ethics committees of Nagoya University School of Medicine (the affiliation of the former principal investigator, Dr. N. Hamajima), Aichi Cancer Center (the affiliation of the present principal investigator, Dr. H. Tanaka), and Tokushima University Hospital.

Questionnaire
-------------

Each study participant was requested to answer a self-administered questionnaire that included items on current and previous diseases, physical activity, frequency of intake of foods and beverages, and smoking and drinking habits. Regarding dietary habits, participants were asked how often they had consumed 53 items of foods and beverages during the previous year. The questionnaire included 2 items on coffee consumption, namely, did the participants drink (1) filtered or instant coffee, and did they drink (2) canned, bottled, or packed coffee. The frequency of coffee intake was divided into 7 categories: rarely, 2 cups or less/week, 3--4 cups/week, 5--6 cups/week, 1--2 cups/day, 3--4 cups/day, and 5 cups or more/day. The total frequency of coffee intake was calculated as the sum of filtered or instant coffee and canned, bottled, or packed coffee. The questionnaire also included 1 item on Japanese green tea consumption (green tea, coarse tea, premium green tea, etc.). The level of intake was classified into 5 categories: rarely, 1--3 cups/day, 4--6 cups/day, 7--9 cups/day, and 10 cups or more/day. Total energy intake and percent energy from fat were calculated using a program developed at the Department of Public Health, Nagoya City University School of Medicine.^[@r23]^ Physical activity during leisure time was estimated by multiplying frequency and duration of light exercise (walking, etc.; 3.4 metabolic equivalents \[METS\]), moderate exercise (jogging, swimming, etc.; 7.0 METS), and heavy exercise (martial arts, marathon, etc.; 10.0 METS). These values were then summed and expressed as MET-hours/week.

The validity of the food frequency questionnaire was examined by comparing the questionnaire findings with data from a 3-day diet record that were collected after an interval of 1 month or shorter, in 29 participants. The Spearman rank correlation coefficient between the frequency of intake obtained from the questionnaire and that obtained from the diet record was 0.51 for coffee and 0.55 for green tea.

Diagnosis of MetS
-----------------

Data on anthropometric measurements (height, weight, and waist circumference), blood pressure, fasting plasma glucose, and serum triglycerides and high-density lipoprotein (HDL) cholesterol were obtained at the time of routine health check-ups. Participants were requested not to eat after 8:00 PM the preceding evening and received their medical check-up during the period from 8:00 AM to 11:30 AM. For 26 participants with missing data on waist circumference, self-reported data from the questionnaire were used instead. A diagnosis of MetS was made by using NCEP ATP III^[@r01]^ and JASSO^[@r03],[@r07]^ criteria. When using the NCEP ATP III criteria, participants were diagnosed as having MetS when they satisfied at least 3 of the following 5 criteria: waist circumference of at least 90 cm in men or at least 80 cm in women; serum triglycerides of at least 150 mg/dl; HDL cholesterol less than 40 mg/dl in men or less than 50 mg/dl in women; systolic blood pressure of at least 130 mm Hg and/or a diastolic blood pressure of at least 85 mm Hg, or hypertension treatment; and fasting plasma glucose of at least 100 mg/dl or diabetes treatment. When using the JASSO criteria, participants were diagnosed as having MetS when they had a waist circumference of at least 85 cm in men or at least 90 cm in women and at least 2 of the following 3 criteria: serum triglycerides of at least 150 mg/dl and/or HDL cholesterol less than 40 mg/dl; systolic blood pressure of at least 130 mm Hg and/or diastolic blood pressure of at least 85 mm Hg, or hypertension treatment; and fasting plasma glucose of at least 110 mg/dl or diabetes treatment.

Statistical analysis
--------------------

The associations of coffee and green tea consumption with the prevalence of MetS and its components were examined using multiple logistic regression analysis, after adjustment for sex, age (continuous), total energy intake (quartiles), leisure-time physical activity (quartiles), and smoking (current, no, ex-smoker) and drinking habits (current drinker, other). In the analysis of green tea consumption, the frequency of coffee consumption was considered as a potential confounder and additionally adjusted for. The amount of coffee consumption was re-classified into 3 groups (\<1.5 cups/day, 1.5 to \<3 cups/day, ≥3 cups/day), and green tea consumption was re-classified into 3 categories (\<1 cup/day, 1 to ≤3 cups/day, ≥4 cups/day), so that the numbers of participants in the categories were as close to equal as possible. The category with the lowest intake was used as the reference in both analyses. Odds ratios (ORs) and profile likelihood 95% CIs are presented. The dose-response relationships of coffee and green tea consumption with MetS were assessed by using ordinal categorical variables of 1, 2, and 3 for each category of consumption. Likelihood-ratio tests were performed in this analysis. A 2-tailed *P* value of less than 0.05 was considered significant. All statistical analyses were done using the SAS software package (version 8.2).^[@r24]^

RESULTS
=======

Table [1](#tbl01){ref-type="table"} shows the descriptive data for age, anthropometric measurements, blood pressure, blood biochemical tests, total energy intake, physical activity, frequency of coffee and green tea consumption, and smoking and drinking habits, according to sex. Mean age was 52.2 years for men and 52.4 years for women. Median frequency of coffee consumption was 11.5 cups/week for men and 10.6 cups/week for women. Median green tea consumption was 2 cups/day for men and women.

###### Characteristics of the study participants

                                                    Men (No. = 409)    Women (No. = 145)
  ------------------------------------------------- ------------------ -------------------
  Age (years)^a^                                    52.2 (9.4)         52.4 (9.1)
  Height (cm)^a^                                    169.3 (5.9)        156.6 (6.1)
  Weight (kg)^a^                                    69.5 (11.1)        55.5 (7.4)
  Body mass index (kg/m^2^)^a^                      24.2 (3.3)         22.7 (3.2)
  Waist circumference (cm)^a^                       86.0 (9.0)         80.3 (9.3)
  Systolic blood pressure (mm Hg)^a^                120.1 (14.6)       115.3 (15.2)
  Diastolic blood pressure (mm Hg)^a^               73.7 (10.6)        68.5 (10.5)
  Triglycerides (mg/dl)^b^                          103 (73, 149)      79 (59, 109)
  High-density lipoprotein cholesterol (mg/dl)^a^   55.5 (16.6)        65.9 (14.4)
  Fasting plasma glucose (mg/dl)^a^                 102.7 (23.2)       97.9 (24.6)
  Total energy intake (kcal/day)^a^                 1902 (332)         1539 (220)
  Physical activity (MET-hours/week)^b^             7.7 (1.3, 21.9)    5.1 (0.4, 15.3)
  Coffee consumption (cups/week)^b^                 11.5 (5.6, 24.6)   10.6 (3.6, 11.5)
  Green tea consumption (cups/day)^b^               2 (2, 2)           2 (2, 5)
                                                                       
  Smoking habit (No., %)                                                
   Current                                          109 (26.7)         12 (8.3)
   Past                                             169 (41.3)         15 (10.3)
   No                                               131 (32.0)         118 (81.4)
  Drinking habit (No., %)                                               
   Current                                          306 (74.8)         59 (40.7)
   Past                                             7 (1.7)            2 (1.4)
   No                                               96 (23.5)          84 (57.9)

^a^Mean (SD).

^b^Median (25%, 75%).

Participants with a higher level of coffee consumption were younger and more likely to be male (data not shown). After adjustment for age and sex, participants who drank more coffee also had lower systolic and diastolic blood pressures. In addition, the proportion of current smokers was higher among those who drank more coffee. Frequency of coffee consumption was weakly inversely correlated with green tea consumption.

Table [2](#tbl02){ref-type="table"} shows sex- and age-adjusted and multivariate-adjusted associations of coffee consumption with the prevalence of MetS and its components, as defined using NCEP ATP III criteria. The overall prevalence of MetS was 114/554 (20.6%). After adjustment for sex, age, total energy intake, physical activity, and smoking and drinking habits, participants who drank more coffee (1.5 to \<3 cups/day or ≥3 cups/day) had significantly lower ORs for MetS than did the reference group (\<1.5 cups/day; *P* = 0.03 and 0.03, respectively). Greater coffee consumption (≥3 cups/day) was also associated with a significantly lower prevalence of high serum triglycerides (≥150 mg/dl; OR = 0.53, 95% CI 0.31--0.90), but not with increased waist circumference, high blood pressure, or high fasting plasma glucose. However, when blood pressure was treated as a continuous variable and treatment for hypertension was additionally adjusted for in multiple regression analysis, a coffee intake of at least 3 cups/day was associated with a change of −4.4 (95% CI −7.2 to −1.5) mm Hg in systolic blood pressure (*P* = 0.003) and a change of −2.3 (95% CI −4.5 to −0.1) mm Hg in diastolic blood pressure (*P* = 0.03). There was a dose-response relationship with coffee consumption for the prevalence of MetS (*P* = 0.03) and increased serum triglycerides (*P* = 0.02).

###### Associations of coffee consumption with the prevalence of metabolic syndrome and its components according to NCEP ATP III criteria (No. = 554)

                                                                                                       Coffee consumption (cups/day)   *P* for trend                           
  ---------------------------------------------------------------------------------------------------- ------------------------------- ------------------- ------------------- ------
  Metabolic syndrome                                                                                                                                                            
   No. of cases/subjects                                                                               47/168                          34/193              33/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.60 (0.36--0.99)   0.61 (0.36--1.03)   0.06
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.56 (0.33--0.95)   0.55 (0.31--0.94)   0.03
                                                                                                                                                                               
  Waist circumference ≥90 cm in men and ≥80 cm in women                                                                                                                        
   No. of cases/subjects                                                                               62/168                          73/193              72/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            1.02 (0.66--1.60)   1.28 (0.82--2.03)   0.27
   Adjusted^b^ OR (95% CI)                                                                             1.00                            1.06 (0.67--1.67)   1.31 (0.82--2.10)   0.25
                                                                                                                                                                                
  Triglycerides ≥150 mg/dl                                                                                                                                                      
   No. of cases/subjects                                                                               45/168                          36/193              40/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.64 (0.38--1.05)   0.61 (0.37--1.02)   0.06
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.60 (0.35--1.02)   0.53 (0.31--0.90)   0.02
                                                                                                                                                                               
  High-density lipoprotein cholesterol \<40 mg/dl in men and \<50 mg/dl in women                                                                                               
   No. of cases/subjects                                                                               27/168                          20/193              27/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.62 (0.33--1.16)   0.92 (0.50--1.68)   0.77
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.56 (0.29--1.07)   0.69 (0.37--1.31)   0.27
                                                                                                                                                                               
  Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment                                                                           
   No. of cases/subjects                                                                               62/168                          61/193              49/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.97 (0.61--1.55)   0.79 (0.48--1.28)   0.34
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.89 (0.55--1.45)   0.82 (0.49--1.36)   0.44
                                                                                                                                                                               
  Fasting plasma glucose ≥100 mg/dl or diabetes treatment                                                                                                                      
   No. of cases/subjects                                                                               77/168                          68/193              79/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.74 (0.48--1.16)   0.86 (0.55--1.35)   0.53
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.74 (0.47--1.18)   0.81 (0.51--1.30)   0.40

^a^Adjusted for age and sex.

^b^Adjusted for age, sex, total energy intake, physical activity, and smoking and drinking habits.

Table [3](#tbl03){ref-type="table"} shows sex- and age-adjusted and multivariate-adjusted associations of coffee consumption with the prevalence of MetS and its components, as defined using JASSO criteria. Using these criteria, the prevalence of MetS was 77/554 (13.9%). In multivariate-adjusted models, moderate coffee consumption (1.5 to \<3 cups/day) was significantly associated with lower prevalence of MetS (OR = 0.52, 95% CI 0.27--0.97). Regarding each component of MetS, participants who drank more coffee (≥3 cups/day) had a significantly lower OR for dyslipidemia (OR = 0.54, 95% CI 0.33--0.89). Moderate coffee consumption (1.5 to \<3 cups/day) was associated with a lower OR for high plasma glucose (OR = 0.51, 95% CI 0.28--0.93). The *P* for trend for the association with coffee consumption was 0.09 for MetS and 0.02 for dyslipidemia.

###### Associations of coffee consumption with the prevalence of metabolic syndrome and its components according to JASSO criteria (No. = 554)

                                                                                                       Coffee consumption (cups/day)   *P* for trend                           
  ---------------------------------------------------------------------------------------------------- ------------------------------- ------------------- ------------------- ------
  Metabolic syndrome                                                                                                                                                            
   No. of cases/subjects                                                                               32/168                          21/193              24/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.58 (0.31--1.05)   0.62 (0.34--1.12)   0.10
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.52 (0.27--0.97)   0.59 (0.32--1.10)   0.09
                                                                                                                                                                               
  Waist circumference ≥85 cm in men and ≥90 cm in women                                                                                                                        
   No. of cases/subjects                                                                               76/168                          72/193              91/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.81 (0.52--1.29)   0.94 (0.60--1.48)   0.83
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.77 (0.48--1.23)   0.93 (0.58--1.49)   0.81
                                                                                                                                                                               
  Triglycerides ≥150 mg/dl or high-density lipoprotein cholesterol \<40 mg/dl                                                                                                  
   No. of cases/subjects                                                                               54/168                          44/193              49/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.65 (0.40--1.04)   0.63 (0.39--1.01)   0.05
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.61 (0.37--1.00)   0.54 (0.33--0.89)   0.02
                                                                                                                                                                               
  High-density lipoprotein cholesterol \<40 mg/dl                                                                                                                              
   No. of cases/subjects                                                                               18/168                          18/193              24/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.93 (0.46--1.88)   1.09 (0.56--2.15)   0.79
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.83 (0.40--1.74)   0.84 (0.41--1.72)   0.65
                                                                                                                                                                               
  Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment                                                                           
   No. of cases/subjects                                                                               62/168                          61/193              49/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.97 (0.61--1.55)   0.79 (0.48--1.28)   0.34
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.89 (0.55--1.45)   0.82 (0.49--1.36)   0.44
                                                                                                                                                                               
  Fasting plasma glucose ≥110 mg/dl or diabetes treatment                                                                                                                      
   No. of cases/subjects                                                                               40/168                          22/193              27/193               
   Adjusted^a^ OR (95% CI)                                                                             1.00                            0.49 (0.27--0.87)   0.64 (0.36--1.13)   0.10
   Adjusted^b^ OR (95% CI)                                                                             1.00                            0.51 (0.28--0.93)   0.65 (0.36--1.17)   0.13

^a^Adjusted for age and sex.

^b^Adjusted for age, sex, total energy intake, physical activity, and smoking and drinking habits.

The results of Tables [2](#tbl02){ref-type="table"} and [3](#tbl03){ref-type="table"} did not change when percent energy intake from fat and frequency of green tea consumption were considered as potential confounders and were additionally adjusted for (data not shown).

Tables [4](#tbl04){ref-type="table"} and [5](#tbl05){ref-type="table"} show the associations between green tea consumption and the prevalence of MetS based on the NCEP ATP III and JASSO criteria, respectively. A higher green tea intake (≥4 cups/day) was not significantly associated with MetS or any of its components, regardless of whether the NCEP ATP III or JASSO criteria were used for diagnosis.

###### Associations of green tea consumption with the prevalence of metabolic syndrome and its components according NCEP ATP III criteria (No. = 554)

                                                                                                       Green tea consumption (cups/day)   *P* for trend                           
  ---------------------------------------------------------------------------------------------------- ---------------------------------- ------------------- ------------------- ------
  Metabolic syndrome                                                                                                                                                               
   No. of cases/subjects                                                                               16/89                              60/310              38/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.00 (0.55--1.90)   1.25 (0.64--2.50)   0.43
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.01 (0.54--1.95)   1.14 (0.57--2.34)   0.66
                                                                                                                                                                                  
  Waist circumference ≥90 cm in men and ≥80 cm in women                                                                                                                           
   No. of cases/subjects                                                                               30/89                              115/310             62/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.15 (0.70--1.93)   0.99 (0.56--1.77)   0.85
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.21 (0.72--2.07)   1.01 (0.56--1.83)   0.88
                                                                                                                                                                                  
  Triglycerides ≥150 mg/dl                                                                                                                                                         
   No. of cases/subjects                                                                               17/89                              73/310              31/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.31 (0.74--2.44)   1.28 (0.65--2.56)   0.55
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.38 (0.76--2.63)   1.18 (0.59--2.44)   0.76
                                                                                                                                                                                  
  High-density lipoprotein cholesterol \<40 mg/dl in men and \<50 mg/dl in women                                                                                                  
   No. of cases/subjects                                                                               9/89                               40/310              25/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.28 (0.62--2.92)   1.61 (0.72--3.89)   0.24
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.23 (0.58--2.88)   1.49 (0.64--3.69)   0.35
                                                                                                                                                                                  
  Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment                                                                              
   No. of cases/subjects                                                                               23/89                              90/310              59/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               0.97 (0.55--1.72)   1.28 (0.69--2.40)   0.33
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.01 (0.57--1.82)   1.21 (0.64--2.32)   0.49
                                                                                                                                                                                  
  Fasting plasma glucose ≥100 mg/dl or diabetes treatment                                                                                                                         
   No. of cases/subjects                                                                               41/89                              123/310             60/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               0.64 (0.39--1.05)   0.68 (0.38--1.20)   0.26
   Adjusted^b^ OR (95% CI)                                                                             1.00                               0.63 (0.38--1.07)   0.73 (0.40--1.32)   0.40

^a^Adjusted for age and sex.

^b^Adjusted for age, sex, total energy intake, physical activity, smoking and drinking habits, and coffee consumption.

###### Associations of green tea consumption with the prevalence of metabolic syndrome and its components according to JASSO criteria (No. = 554)

                                                                                                       Green tea consumption (cups/day)   *P* for trend                           
  ---------------------------------------------------------------------------------------------------- ---------------------------------- ------------------- ------------------- ------
  Metabolic syndrome                                                                                                                                                               
   No. of cases/subjects                                                                               11/89                              41/310              25/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               0.98 (0.49--2.09)   1.38 (0.64--3.14)   0.33
   Adjusted^b^ OR (95% CI)                                                                             1.00                               0.99 (0.49--2.17)   1.18 (0.53--2.75)   0.63
                                                                                                                                                                                  
  Waist circumference ≥85 cm in men and ≥90 cm in women                                                                                                                           
   No. of cases/subjects                                                                               37/89                              145/310             57/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.13 (0.68--1.88)   1.00 (0.56--1.81)   0.93
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.13 (0.67--1.90)   0.87 (0.48--1.60)   0.57
                                                                                                                                                                                  
  Triglycerides ≥150 mg/dl or high-density lipoprotein cholesterol \<40 mg/dl                                                                                                     
   No. of cases/subjects                                                                               20/89                              90/310              37/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.39 (0.80--2.48)   1.29 (0.68--2.48)   0.54
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.43 (0.81--2.61)   1.18 (0.61--2.33)   0.77
                                                                                                                                                                                  
  High-density lipoprotein cholesterol \<40 mg/dl                                                                                                                                 
   No. of cases/subjects                                                                               7/89                               36/310              17/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               1.49 (0.67--3.78)   1.74 (0.70--4.76)   0.27
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.44 (0.63--3.75)   1.64 (0.63--4.65)   0.34
                                                                                                                                                                                  
  Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or hypertension treatment                                                                              
   No. of cases/subjects                                                                               23/89                              90/310              59/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               0.97 (0.55--1.72)   1.28 (0.69--2.40)   0.33
   Adjusted^b^ OR (95% CI)                                                                             1.00                               1.01 (0.57--1.82)   1.21 (0.64--2.32)   0.49
                                                                                                                                                                                  
  Fasting plasma glucose ≥110 mg/dl or diabetes treatment                                                                                                                         
   No. of cases/subjects                                                                               14/89                              49/310              26/155               
   Adjusted^a^ OR (95% CI)                                                                             1.00                               0.83 (0.43--1.68)   0.84 (0.40--1.81)   0.70
   Adjusted^b^ OR (95% CI)                                                                             1.00                               0.84 (0.43--1.71)   0.84 (0.39--1.86)   0.70

^a^Adjusted for age and sex.

^b^Adjusted for age, sex, total energy intake, physical activity, smoking and drinking habits, and coffee consumption.

DISCUSSION
==========

In the present study, coffee consumption was inversely correlated with the prevalence of MetS, as defined by the NCEP ATP III criteria, after adjustment for sex, age, total energy intake, leisure-time physical activity, and smoking and drinking habits. Earlier studies are inconsistent regarding the association of coffee consumption and MetS. Hino et al^[@r15]^ reported a significant inverse correlation in a cross-sectional study of 1902 Japanese older than 40 years. They also observed significant inverse correlations in all 5 MetS components (Japanese criteria) except low HDL cholesterol. During the preparation of this manuscript, Matsuura et al^[@r16]^ reported that habitual coffee consumption (≥4 cups/day) was associated with a significantly lower prevalence of MetS (Japanese criteria), and significantly lower blood pressure and serum triglycerides, in men. In contrast, no significant association was observed between coffee consumption and the incidence rate of MetS in a 9-year prospective study of 9514 subjects in the United States.^[@r08]^ In addition, coffee consumption was not significantly associated with MetS or any of its components in 283 Dutch men and women followed for 15 years.^[@r17]^ However, the age of that study population was rather young (27 years at baseline), and the prevalence of MetS at the completion of follow-up was only 8.1% among men and 0% among women.^[@r17]^

In our study, serum triglyceride level was significantly inversely correlated with coffee consumption. At least 4 cross-sectional studies performed in Japan, including 2 on MetS,^[@r15],[@r16]^ reported an inverse correlation between coffee consumption and serum triglyceride level. In 4587 self-defense officials, consumption of instant but not brewed coffee was significantly correlated with lower serum triglyceride levels.^[@r25]^ There was also an inverse relationship between coffee drinking and serum triglyceride level in 1591 male office workers in Osaka.^[@r26]^ However, among 623 adults in Germany, there was a significant positive relation between serum caffeine, an important chemical component of coffee, and serum triglyceride level.^[@r27]^ It is possible that substances in coffee other than caffeine have biological effects that decrease serum triglyceride level. In randomized controlled trials conducted in the 1990s, administration of 5 to 6 cups/day of boiled coffee^[@r28]^ or lipids extracted from Arabica coffee beans^[@r29]^ significantly increased plasma or serum levels of total cholesterol and triglycerides. However, this lipid fraction is believed to be absent from filtered and instant coffee, which are the most common types of coffee in Japan.

Regarding low HDL cholesterol levels, the results of 2 clinical trials in the United States showed a significant increase in serum HDL cholesterol after consumption of 4 to 8 cups/day of filtered coffee for 8 weeks.^[@r30],[@r31]^ However, in studies of Japanese populations that were conducted in the 1990s, no significant correlation was observed between coffee consumption and serum HDL cholesterol level.^[@r25],[@r26]^ In the study by Hino et al,^[@r15]^ low HDL cholesterol was the only component of MetS that was not correlated with coffee consumption. Moreover, there was no significant correlation of intakes of caffeinated and decaffeinated coffee with plasma HDL cholesterol level in a sample selected from the 2 US cohort studies.^[@r32]^ In the present study population, the ORs for low HDL cholesterol levels were lower than unity (0.56 for 1.5 to \<3 cups/day and 0.69 for \>3 cups/day), but not significantly so.

There have been a large number of epidemiologic studies of the link between coffee consumption and glucose metabolism, and recent meta-analyses of cohort studies concluded that coffee and decaffeinated coffee may be protective against type 2 diabetes/impaired glucose tolerance and that habitual consumption of 1 cup/day of coffee was associated with an approximately 7% reduction in the risk of type 2 diabetes.^[@r13],[@r14]^ The hypothesized biological mechanisms include reduced intestinal glucose absorption through inhibition of glucose-6-phosphate translocase 1, decreased hepatic output of glucose and the antioxidant effects of chlorogenic acid, and improved insulin sensitivity due to magnesium.^[@r33]^ In the present study, a significant inverse association with moderate coffee consumption (1.5 to \<3 cups/day) was seen when a plasma glucose level of 110 mg/dl, but not 100 mg/dl, was used as the cut-off point. This may be due to the higher specificity of detecting impaired glucose tolerance/diabetes when 110 mg/dl is used as a cut-off point.

A cross-sectional study on self-defense officials in Japan showed a significant inverse correlation between coffee consumption and systolic and diastolic blood pressures.^[@r34]^ In addition, a Japanese cross-over study reported that a coffee intake of 3.3 to 3.6 cups/day for 4 weeks was associated with significant reductions in systolic and diastolic blood pressures in male habitual alcohol drinkers.^[@r35]^ A small but significant reduction in the risk of hypertension (7%--12%) was also observed among women who consumed 4 to 5 cups/day or at least 6 cups/day of caffeinated coffee in a large-scale cohort study in the United States.^[@r36]^ On the other hand, in a recent meta-analysis of 6 prospective studies in the United States and Europe, there was an inverse J-relation between coffee consumption and hypertension risk, and the pooled rate ratios of hypertension associated with a coffee intake of 3 to 5 cups/day and more than 5 cups/day were 1.07 (95% CI 0.96--1.20) and 1.08 (0.96--1.21), respectively, when an intake less than 1 cup/day was used as the reference.^[@r37]^ In another meta-analysis, caffeine administration resulted in an acute increase in systolic and diastolic blood pressures, but there was no prolonged increase or decrease in blood pressure in patients with hypertension, after coffee consumption of at least 3 cups/day for 2 weeks.^[@r38]^ In the present study, although high coffee consumption (≥3 cups/day) was correlated with significantly lower systolic and diastolic blood pressures when analyzed as a continuous variable, it was not correlated with hypertension prevalence, perhaps because inverse correlations were observed even within the normal range of blood pressures, and because loss of information occurred during the conversion from continuous to categorical variables.

Two cross-sectional data sets, 1 from Japanese adults^[@r15]^ and 1 from American Indians,^[@r39]^ showed inverse correlations between the frequency of coffee consumption and waist circumference. In a prospective study of US women, changes in the intakes of caffeinated and decaffeinated coffee were significantly associated with weight gain.^[@r40]^ An experimental study also showed that administration of coffee polyphenols increased energy expenditure and suppressed visceral fat accumulation in mice.^[@r41]^ In contrast, there was no relationship between frequency of coffee consumption and waist circumference among participants of the 2003--2004 National Health and Nutrition Examination Survey in the United States^[@r42]^ or the Amsterdam Growth and Health Longitudinal Study in the Netherlands.^[@r17]^ In our analysis, no significant correlation was found between coffee consumption and either waist circumference or body mass index. Differences in age, ethnicity, amount and type of coffee consumed, and use of additives such as sugar and milk, might account for the inconsistency. However, the precise reasons remain unclear.

In the current study, a significant inverse dose-response relationship between coffee consumption and MetS prevalence was observed when NCEP ATP III but not JASSO criteria were used for diagnosis. The reason may be that an essential JASSO criterion is increased waist circumference, which was not associated with coffee consumption.

Observational studies of general populations and intervention studies of obese adults showed beneficial effects of high intake of green tea, green tea extracts, and especially (−)-epigallocatechin-3-gallate, on weight reduction^[@r18],[@r43]^ and other cardiovascular risk factors such as serum triglycerides^[@r19]^ and hypertension.^[@r20],[@r44]^ In addition, a significant association between high green tea consumption (\>6 cups/day) and reduced risk of diabetes was reported in a Japanese population.^[@r21]^ In the present study, however, there was no correlation between green tea consumption and the prevalence of MetS or any of its components. One explanation for the lack of a correlation in our study may be that the interindividual variation in green tea consumption was rather low, as indicated by the narrow interquartile ranges. In addition, the question on Japanese green tea included coarse tea, which contains relatively little (−)-epigallocatechin-3-gallate.

The current study has several limitations. First, because of the cross-sectional study design, the temporal relationship between coffee consumption and MetS development is obscure. It is also possible that the presence of chronic diseases led to modifications in dietary habits. For instance, persons who had received a diagnosis of diabetes might have refrained from drinking coffee with sugar. When participants receiving treatment for diabetes were excluded, the ORs for MetS (NCEP ATP III definition) associated with coffee consumption (1.5 to \<3 cups/day and ≥3 cups/day) were 0.66 (95% CI 0.37--1.16) and 0.60 (95% CI 0.33--1.09), respectively (*P* for trend = 0.09, *n* = 516). Second, information on additives such as milk, sugar, and cream was lacking, and we could not account for these factors in the analysis. Third, we could not distinguish between intake of caffeinated and decaffeinated coffee, although use of decaffeinated coffee is not common in Japan. Fourth, information on coffee and green tea consumption was based on self-reporting, and some degree of misclassification is inevitable. Finally, the number of study participants was rather small.

In summary, these cross-sectional data showed an inverse correlation between coffee consumption and MetS when NCEP ATP III criteria were used for diagnosis, mainly due to the lower prevalence of hypertriglyceridemia. This association warrants further prospective studies for the purpose of causal inference.
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